[1]
“Comparative Effects of Repaglinide Versus Glibenclamide on Glycemic Control in Newly Diagnosed Type 2 Diabetic Patients”, Tikrit J. Pharm. Sci., vol. 8, no. 1, pp. 22–28, Apr. 2023, doi: 10.25130/tjphs.2012.8.1.4.22.28.